Ken Surprenant, Lindsay Murray, Karen Merritt, Maria Hopkins, Joanne McIntyre
{"title":"Give Patients the Choice to Test for DPD Deficiency Before Fluoropyrimidine Chemotherapy.","authors":"Ken Surprenant, Lindsay Murray, Karen Merritt, Maria Hopkins, Joanne McIntyre","doi":"10.1200/OP.24.00443","DOIUrl":null,"url":null,"abstract":"<p><p>Patients, not physicians, should decide if DPYD screening is right for them before FU/Xeloda chemotherapy.</p>","PeriodicalId":14612,"journal":{"name":"JCO oncology practice","volume":" ","pages":"264-265"},"PeriodicalIF":4.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO oncology practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/OP.24.00443","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Patients, not physicians, should decide if DPYD screening is right for them before FU/Xeloda chemotherapy.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
